nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—ADRB2—chronic obstructive pulmonary disease	0.126	0.291	CbGaD
Asenapine—SLC6A4—chronic obstructive pulmonary disease	0.115	0.265	CbGaD
Asenapine—CYP1A2—chronic obstructive pulmonary disease	0.104	0.241	CbGaD
Asenapine—HTR2A—chronic obstructive pulmonary disease	0.088	0.203	CbGaD
Asenapine—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0613	0.159	CbGbCtD
Asenapine—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0603	0.156	CbGbCtD
Asenapine—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0464	0.12	CbGbCtD
Asenapine—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0464	0.12	CbGbCtD
Asenapine—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0457	0.118	CbGbCtD
Asenapine—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0457	0.118	CbGbCtD
Asenapine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.012	0.0311	CbGbCtD
Asenapine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0116	0.0301	CbGbCtD
Asenapine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0116	0.0301	CbGbCtD
Asenapine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0104	0.0269	CbGbCtD
Asenapine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00977	0.0253	CbGbCtD
Asenapine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0066	0.0171	CbGbCtD
Asenapine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00629	0.0163	CbGbCtD
Asenapine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00561	0.0145	CbGbCtD
Asenapine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00463	0.215	CbGeAlD
Asenapine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00329	0.00852	CbGbCtD
Asenapine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00311	0.00805	CbGbCtD
Asenapine—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.0027	0.125	CbGeAlD
Asenapine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00168	0.0782	CbGeAlD
Asenapine—UGT1A4—respiratory system—chronic obstructive pulmonary disease	0.00142	0.0662	CbGeAlD
Asenapine—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000535	0.0249	CbGeAlD
Asenapine—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000501	0.0233	CbGeAlD
Asenapine—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.000487	0.0227	CbGeAlD
Asenapine—HRH2—lung—chronic obstructive pulmonary disease	0.000474	0.022	CbGeAlD
Asenapine—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000455	0.0212	CbGeAlD
Asenapine—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000454	0.0211	CbGeAlD
Asenapine—Amoxapine—SLC6A4—chronic obstructive pulmonary disease	0.000432	0.317	CrCbGaD
Asenapine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000429	0.0199	CbGeAlD
Asenapine—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000427	0.0198	CbGeAlD
Asenapine—HTR7—connective tissue—chronic obstructive pulmonary disease	0.000399	0.0186	CbGeAlD
Asenapine—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000365	0.017	CbGeAlD
Asenapine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000362	0.0168	CbGeAlD
Asenapine—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000343	0.016	CbGeAlD
Asenapine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000339	0.0158	CbGeAlD
Asenapine—Loxapine—SLC6A4—chronic obstructive pulmonary disease	0.000337	0.248	CrCbGaD
Asenapine—HTR7—trachea—chronic obstructive pulmonary disease	0.000335	0.0156	CbGeAlD
Asenapine—Amoxapine—HTR2A—chronic obstructive pulmonary disease	0.000332	0.244	CrCbGaD
Asenapine—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000308	0.0143	CbGeAlD
Asenapine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000298	0.0139	CbGeAlD
Asenapine—ADRB1—lung—chronic obstructive pulmonary disease	0.000294	0.0137	CbGeAlD
Asenapine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000293	0.0136	CbGeAlD
Asenapine—SLC6A4—lung—chronic obstructive pulmonary disease	0.000284	0.0132	CbGeAlD
Asenapine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000283	0.0132	CbGeAlD
Asenapine—HTR2B—lung—chronic obstructive pulmonary disease	0.000281	0.0131	CbGeAlD
Asenapine—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00315	CcSEcCtD
Asenapine—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00315	CcSEcCtD
Asenapine—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000274	0.0127	CbGeAlD
Asenapine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000273	0.0127	CbGeAlD
Asenapine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000271	0.00311	CcSEcCtD
Asenapine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.0031	CcSEcCtD
Asenapine—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00308	CcSEcCtD
Asenapine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000264	0.00304	CcSEcCtD
Asenapine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00299	CcSEcCtD
Asenapine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.00298	CcSEcCtD
Asenapine—Loxapine—HTR2A—chronic obstructive pulmonary disease	0.000259	0.191	CrCbGaD
Asenapine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00297	CcSEcCtD
Asenapine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00297	CcSEcCtD
Asenapine—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00297	CcSEcCtD
Asenapine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000258	0.00297	CcSEcCtD
Asenapine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000256	0.00294	CcSEcCtD
Asenapine—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00294	CcSEcCtD
Asenapine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000255	0.00293	CcSEcCtD
Asenapine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000254	0.00292	CcSEcCtD
Asenapine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00291	CcSEcCtD
Asenapine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00289	CcSEcCtD
Asenapine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00289	CcSEcCtD
Asenapine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00289	CcSEcCtD
Asenapine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00289	CcSEcCtD
Asenapine—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.00288	CcSEcCtD
Asenapine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000251	0.00288	CcSEcCtD
Asenapine—HRH1—trachea—chronic obstructive pulmonary disease	0.00025	0.0116	CbGeAlD
Asenapine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000249	0.0116	CbGeAlD
Asenapine—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00286	CcSEcCtD
Asenapine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000248	0.00285	CcSEcCtD
Asenapine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00284	CcSEcCtD
Asenapine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00283	CcSEcCtD
Asenapine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000246	0.00283	CcSEcCtD
Asenapine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000246	0.00283	CcSEcCtD
Asenapine—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000246	0.0114	CbGeAlD
Asenapine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000245	0.00281	CcSEcCtD
Asenapine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00281	CcSEcCtD
Asenapine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00281	CcSEcCtD
Asenapine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00281	CcSEcCtD
Asenapine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000243	0.0028	CcSEcCtD
Asenapine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00279	CcSEcCtD
Asenapine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00279	CcSEcCtD
Asenapine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000242	0.00278	CcSEcCtD
Asenapine—HTR7—lung—chronic obstructive pulmonary disease	0.000241	0.0112	CbGeAlD
Asenapine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000241	0.00277	CcSEcCtD
Asenapine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00024	0.00275	CcSEcCtD
Asenapine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00275	CcSEcCtD
Asenapine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00275	CcSEcCtD
Asenapine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00273	CcSEcCtD
Asenapine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00273	CcSEcCtD
Asenapine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00273	CcSEcCtD
Asenapine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00273	CcSEcCtD
Asenapine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000236	0.00271	CcSEcCtD
Asenapine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00268	CcSEcCtD
Asenapine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00268	CcSEcCtD
Asenapine—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.00267	CcSEcCtD
Asenapine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000232	0.00266	CcSEcCtD
Asenapine—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000231	0.00266	CcSEcCtD
Asenapine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00265	CcSEcCtD
Asenapine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00263	CcSEcCtD
Asenapine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000229	0.00263	CcSEcCtD
Asenapine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000229	0.00263	CcSEcCtD
Asenapine—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00263	CcSEcCtD
Asenapine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000228	0.0106	CbGeAlD
Asenapine—DRD2—lung—chronic obstructive pulmonary disease	0.000228	0.0106	CbGeAlD
Asenapine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00261	CcSEcCtD
Asenapine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00261	CcSEcCtD
Asenapine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00259	CcSEcCtD
Asenapine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00258	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000224	0.00257	CcSEcCtD
Asenapine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00256	CcSEcCtD
Asenapine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00256	CcSEcCtD
Asenapine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00256	CcSEcCtD
Asenapine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000222	0.00255	CcSEcCtD
Asenapine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00255	CcSEcCtD
Asenapine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00255	CcSEcCtD
Asenapine—ADRA2C—lung—chronic obstructive pulmonary disease	0.000221	0.0103	CbGeAlD
Asenapine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00253	CcSEcCtD
Asenapine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00252	CcSEcCtD
Asenapine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00252	CcSEcCtD
Asenapine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00251	CcSEcCtD
Asenapine—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00251	CcSEcCtD
Asenapine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000217	0.0025	CcSEcCtD
Asenapine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000216	0.00248	CcSEcCtD
Asenapine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00247	CcSEcCtD
Asenapine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.00244	CcSEcCtD
Asenapine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00242	CcSEcCtD
Asenapine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.00241	CcSEcCtD
Asenapine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00241	CcSEcCtD
Asenapine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00241	CcSEcCtD
Asenapine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00241	CcSEcCtD
Asenapine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000209	0.00972	CbGeAlD
Asenapine—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000209	0.0024	CcSEcCtD
Asenapine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00238	CcSEcCtD
Asenapine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00238	CcSEcCtD
Asenapine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00238	CcSEcCtD
Asenapine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00237	CcSEcCtD
Asenapine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00237	CcSEcCtD
Asenapine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00237	CcSEcCtD
Asenapine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00236	CcSEcCtD
Asenapine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00233	CcSEcCtD
Asenapine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000202	0.00232	CcSEcCtD
Asenapine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.00232	CcSEcCtD
Asenapine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00232	CcSEcCtD
Asenapine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00232	CcSEcCtD
Asenapine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00228	CcSEcCtD
Asenapine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00228	CcSEcCtD
Asenapine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00227	CcSEcCtD
Asenapine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00224	CcSEcCtD
Asenapine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00224	CcSEcCtD
Asenapine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00223	CcSEcCtD
Asenapine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00223	CcSEcCtD
Asenapine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00223	CcSEcCtD
Asenapine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00222	CcSEcCtD
Asenapine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00222	CcSEcCtD
Asenapine—CYP1A2—lung—chronic obstructive pulmonary disease	0.000192	0.00894	CbGeAlD
Asenapine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000192	0.0022	CcSEcCtD
Asenapine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00219	CcSEcCtD
Asenapine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00219	CcSEcCtD
Asenapine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00218	CcSEcCtD
Asenapine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00215	CcSEcCtD
Asenapine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00213	CcSEcCtD
Asenapine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00213	CcSEcCtD
Asenapine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00212	CcSEcCtD
Asenapine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00211	CcSEcCtD
Asenapine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.0021	CcSEcCtD
Asenapine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000182	0.0021	CcSEcCtD
Asenapine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000181	0.00208	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00207	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00207	CcSEcCtD
Asenapine—HRH1—lung—chronic obstructive pulmonary disease	0.00018	0.00837	CbGeAlD
Asenapine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00206	CcSEcCtD
Asenapine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00206	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00203	CcSEcCtD
Asenapine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00203	CcSEcCtD
Asenapine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00203	CcSEcCtD
Asenapine—ADRA2A—lung—chronic obstructive pulmonary disease	0.000177	0.00822	CbGeAlD
Asenapine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00202	CcSEcCtD
Asenapine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00202	CcSEcCtD
Asenapine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00202	CcSEcCtD
Asenapine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00201	CcSEcCtD
Asenapine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.002	CcSEcCtD
Asenapine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000174	0.002	CcSEcCtD
Asenapine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000173	0.00198	CcSEcCtD
Asenapine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000172	0.00198	CcSEcCtD
Asenapine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00197	CcSEcCtD
Asenapine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00197	CcSEcCtD
Asenapine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00197	CcSEcCtD
Asenapine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00196	CcSEcCtD
Asenapine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00196	CcSEcCtD
Asenapine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00196	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00196	CcSEcCtD
Asenapine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00195	CcSEcCtD
Asenapine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00195	CcSEcCtD
Asenapine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00194	CcSEcCtD
Asenapine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00194	CcSEcCtD
Asenapine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00193	CcSEcCtD
Asenapine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000167	0.00192	CcSEcCtD
Asenapine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00192	CcSEcCtD
Asenapine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00191	CcSEcCtD
Asenapine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.0019	CcSEcCtD
Asenapine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00189	CcSEcCtD
Asenapine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.00189	CcSEcCtD
Asenapine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.00188	CcSEcCtD
Asenapine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.00187	CcSEcCtD
Asenapine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000162	0.00187	CcSEcCtD
Asenapine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00186	CcSEcCtD
Asenapine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00185	CcSEcCtD
Asenapine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00184	CcSEcCtD
Asenapine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00182	CcSEcCtD
Asenapine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000156	0.00179	CcSEcCtD
Asenapine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00178	CcSEcCtD
Asenapine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.00178	CcSEcCtD
Asenapine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.00178	CcSEcCtD
Asenapine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.00178	CcSEcCtD
Asenapine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.00177	CcSEcCtD
Asenapine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00174	CcSEcCtD
Asenapine—HTR2A—lung—chronic obstructive pulmonary disease	0.00015	0.00699	CbGeAlD
Asenapine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00168	CcSEcCtD
Asenapine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00168	CcSEcCtD
Asenapine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.00168	CcSEcCtD
Asenapine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000143	0.00164	CcSEcCtD
Asenapine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00163	CcSEcCtD
Asenapine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00163	CcSEcCtD
Asenapine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00161	CcSEcCtD
Asenapine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000139	0.0016	CcSEcCtD
Asenapine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00158	CcSEcCtD
Asenapine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00154	CcSEcCtD
Asenapine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.00151	CcSEcCtD
Asenapine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000131	0.00151	CcSEcCtD
Asenapine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000128	0.00147	CcSEcCtD
Asenapine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00147	CcSEcCtD
Asenapine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.00145	CcSEcCtD
Asenapine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000126	0.00145	CcSEcCtD
Asenapine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00144	CcSEcCtD
Asenapine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00144	CcSEcCtD
Asenapine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00143	CcSEcCtD
Asenapine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00143	CcSEcCtD
Asenapine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00143	CcSEcCtD
Asenapine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00143	CcSEcCtD
Asenapine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00143	CcSEcCtD
Asenapine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.00142	CcSEcCtD
Asenapine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00142	CcSEcCtD
Asenapine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000123	0.00142	CcSEcCtD
Asenapine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00141	CcSEcCtD
Asenapine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000122	0.0014	CcSEcCtD
Asenapine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000122	0.0014	CcSEcCtD
Asenapine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000122	0.0014	CcSEcCtD
Asenapine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.00138	CcSEcCtD
Asenapine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00137	CcSEcCtD
Asenapine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00136	CcSEcCtD
Asenapine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00136	CcSEcCtD
Asenapine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00136	CcSEcCtD
Asenapine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00135	CcSEcCtD
Asenapine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00135	CcSEcCtD
Asenapine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00135	CcSEcCtD
Asenapine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00135	CcSEcCtD
Asenapine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00133	CcSEcCtD
Asenapine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000115	0.00132	CcSEcCtD
Asenapine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00131	CcSEcCtD
Asenapine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.0013	CcSEcCtD
Asenapine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.00128	CcSEcCtD
Asenapine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00124	CcSEcCtD
Asenapine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00123	CcSEcCtD
Asenapine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.00121	CcSEcCtD
Asenapine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.0012	CcSEcCtD
Asenapine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00118	CcSEcCtD
Asenapine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.00114	CcSEcCtD
Asenapine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	9.92e-05	0.00114	CcSEcCtD
Asenapine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.71e-05	0.00112	CcSEcCtD
Asenapine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.62e-05	0.00111	CcSEcCtD
Asenapine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.56e-05	0.0011	CcSEcCtD
Asenapine—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.00101	CcSEcCtD
Asenapine—Agitation—Prednisone—chronic obstructive pulmonary disease	8.78e-05	0.00101	CcSEcCtD
Asenapine—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.73e-05	0.001	CcSEcCtD
Asenapine—Malaise—Prednisone—chronic obstructive pulmonary disease	8.62e-05	0.00099	CcSEcCtD
Asenapine—Syncope—Prednisone—chronic obstructive pulmonary disease	8.57e-05	0.000985	CcSEcCtD
Asenapine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.4e-05	0.000965	CcSEcCtD
Asenapine—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.28e-05	0.000951	CcSEcCtD
Asenapine—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.25e-05	0.000948	CcSEcCtD
Asenapine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	8.14e-05	0.000935	CcSEcCtD
Asenapine—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.11e-05	0.000932	CcSEcCtD
Asenapine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.91e-05	0.000909	CcSEcCtD
Asenapine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.8e-05	0.000896	CcSEcCtD
Asenapine—Shock—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.000882	CcSEcCtD
Asenapine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.65e-05	0.000879	CcSEcCtD
Asenapine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.000875	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.11e-05	0.000816	CcSEcCtD
Asenapine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.1e-05	0.000815	CcSEcCtD
Asenapine—Insomnia—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.00081	CcSEcCtD
Asenapine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.87e-05	0.000789	CcSEcCtD
Asenapine—Rash—Prednisolone—chronic obstructive pulmonary disease	6.77e-05	0.000778	CcSEcCtD
Asenapine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.76e-05	0.000777	CcSEcCtD
Asenapine—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000773	CcSEcCtD
Asenapine—Headache—Prednisolone—chronic obstructive pulmonary disease	6.72e-05	0.000773	CcSEcCtD
Asenapine—Constipation—Prednisone—chronic obstructive pulmonary disease	6.67e-05	0.000766	CcSEcCtD
Asenapine—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.38e-05	0.000732	CcSEcCtD
Asenapine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.75e-05	0.00066	CcSEcCtD
Asenapine—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.000643	CcSEcCtD
Asenapine—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.16e-05	0.000593	CcSEcCtD
Asenapine—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.96e-05	0.00057	CcSEcCtD
Asenapine—Rash—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000565	CcSEcCtD
Asenapine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.000564	CcSEcCtD
Asenapine—Headache—Prednisone—chronic obstructive pulmonary disease	4.89e-05	0.000561	CcSEcCtD
Asenapine—Nausea—Prednisone—chronic obstructive pulmonary disease	4.63e-05	0.000532	CcSEcCtD
Asenapine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.42e-06	6.22e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.42e-06	6.21e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.41e-06	6.2e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.41e-06	6.2e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.41e-06	6.2e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.4e-06	6.19e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.4e-06	6.19e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.39e-06	6.17e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.37e-06	6.16e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.35e-06	6.13e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.33e-06	6.1e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.33e-06	6.09e-05	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	4.31e-06	6.06e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.31e-06	6.06e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.3e-06	6.05e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.3e-06	6.05e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.22e-06	5.94e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.21e-06	5.92e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.16e-06	5.85e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.16e-06	5.85e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.14e-06	5.83e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	4.13e-06	5.81e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.1e-06	5.77e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.09e-06	5.75e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.08e-06	5.75e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.07e-06	5.72e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.06e-06	5.71e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.03e-06	5.67e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4e-06	5.63e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4e-06	5.63e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.97e-06	5.59e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.97e-06	5.59e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.97e-06	5.58e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	3.95e-06	5.56e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.93e-06	5.54e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.93e-06	5.52e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.92e-06	5.51e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.92e-06	5.51e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.91e-06	5.5e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.9e-06	5.48e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.89e-06	5.47e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.88e-06	5.46e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.88e-06	5.46e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.86e-06	5.43e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.85e-06	5.42e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.85e-06	5.42e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.83e-06	5.39e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.78e-06	5.32e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.74e-06	5.27e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.74e-06	5.26e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.73e-06	5.25e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.73e-06	5.24e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.72e-06	5.23e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.7e-06	5.21e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.7e-06	5.2e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.69e-06	5.2e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.69e-06	5.19e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.67e-06	5.17e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.67e-06	5.16e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.65e-06	5.14e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.64e-06	5.12e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.62e-06	5.1e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.59e-06	5.06e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.58e-06	5.04e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.57e-06	5.03e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.57e-06	5.02e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.56e-06	5e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.55e-06	4.99e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.54e-06	4.98e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.53e-06	4.97e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.52e-06	4.95e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.49e-06	4.91e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.48e-06	4.9e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.47e-06	4.89e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.46e-06	4.87e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.44e-06	4.84e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.41e-06	4.8e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.39e-06	4.78e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.39e-06	4.77e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.38e-06	4.75e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.36e-06	4.73e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	3.35e-06	4.72e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.35e-06	4.71e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.32e-06	4.67e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.32e-06	4.67e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.3e-06	4.65e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.3e-06	4.65e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.3e-06	4.64e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.29e-06	4.63e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.27e-06	4.6e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.24e-06	4.55e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.23e-06	4.54e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.23e-06	4.54e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.21e-06	4.52e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	3.21e-06	4.51e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.18e-06	4.48e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.18e-06	4.47e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.17e-06	4.46e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.16e-06	4.45e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.14e-06	4.42e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.14e-06	4.42e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.14e-06	4.41e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.14e-06	4.41e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.13e-06	4.4e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.1e-06	4.36e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.09e-06	4.34e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.08e-06	4.34e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.08e-06	4.33e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.05e-06	4.29e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.04e-06	4.28e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.03e-06	4.26e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.03e-06	4.26e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.02e-06	4.26e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.02e-06	4.25e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.01e-06	4.24e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.01e-06	4.23e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3e-06	4.22e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.99e-06	4.21e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.99e-06	4.2e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.99e-06	4.2e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.98e-06	4.19e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.97e-06	4.17e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.96e-06	4.17e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.95e-06	4.15e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.94e-06	4.14e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.94e-06	4.14e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.94e-06	4.14e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.93e-06	4.12e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.91e-06	4.1e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.9e-06	4.09e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.89e-06	4.07e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.89e-06	4.06e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.88e-06	4.05e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.87e-06	4.04e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.86e-06	4.03e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.86e-06	4.03e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.86e-06	4.02e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.86e-06	4.02e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.84e-06	3.99e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.82e-06	3.97e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.81e-06	3.95e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.8e-06	3.94e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.78e-06	3.92e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.78e-06	3.91e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.74e-06	3.85e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.73e-06	3.84e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.72e-06	3.83e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.72e-06	3.83e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.68e-06	3.77e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.66e-06	3.74e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.65e-06	3.73e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.62e-06	3.69e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.61e-06	3.68e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.61e-06	3.67e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.59e-06	3.64e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.57e-06	3.62e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.57e-06	3.62e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.56e-06	3.6e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.55e-06	3.58e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.54e-06	3.57e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.53e-06	3.56e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.51e-06	3.54e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.51e-06	3.53e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.51e-06	3.53e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.49e-06	3.5e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.49e-06	3.5e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.48e-06	3.49e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.46e-06	3.46e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.45e-06	3.44e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.44e-06	3.43e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.43e-06	3.43e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.41e-06	3.39e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.4e-06	3.38e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.4e-06	3.38e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.38e-06	3.35e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.38e-06	3.35e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.38e-06	3.35e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.36e-06	3.33e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.36e-06	3.32e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.36e-06	3.32e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.34e-06	3.29e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.32e-06	3.26e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.31e-06	3.25e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.31e-06	3.25e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.3e-06	3.23e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.29e-06	3.23e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.29e-06	3.22e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.29e-06	3.22e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.28e-06	3.21e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.26e-06	3.18e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.26e-06	3.18e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.26e-06	3.17e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.24e-06	3.16e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.23e-06	3.14e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.22e-06	3.12e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.21e-06	3.11e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.2e-06	3.1e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.2e-06	3.09e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.18e-06	3.07e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.18e-06	3.07e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.16e-06	3.04e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.16e-06	3.04e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.15e-06	3.03e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.14e-06	3.01e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.13e-06	3e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.12e-06	2.99e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.12e-06	2.98e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.1e-06	2.96e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.1e-06	2.95e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.09e-06	2.94e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.08e-06	2.93e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.98e-06	2.79e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.98e-06	2.78e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.95e-06	2.74e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.95e-06	2.74e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.94e-06	2.74e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.94e-06	2.73e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.94e-06	2.73e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.93e-06	2.72e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.92e-06	2.71e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.91e-06	2.69e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.91e-06	2.69e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.91e-06	2.68e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.9e-06	2.67e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.87e-06	2.63e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.86e-06	2.61e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.85e-06	2.6e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.85e-06	2.6e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.8e-06	2.53e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.78e-06	2.5e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.77e-06	2.5e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.77e-06	2.49e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.76e-06	2.48e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.74e-06	2.45e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.74e-06	2.45e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.7e-06	2.39e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.69e-06	2.38e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.65e-06	2.31e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.63e-06	2.29e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.6e-06	2.26e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.6e-06	2.25e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.57e-06	2.21e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.49e-06	2.1e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.47e-06	2.07e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.47e-06	2.06e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.46e-06	2.05e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.44e-06	2.02e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.43e-06	2.01e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.37e-06	1.92e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.34e-06	1.88e-05	CbGpPWpGaD
